Prosensa Holding N.V. (RNA) Tops Q2 EPS by 13c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Prosensa Holding N.V. (RNA) Tops Q2 EPS by 13c

Avidity Biosciences Reports Second Quarter 2023 Financial Results and Recent Highlights

August 8, 2023 4:05 PM EDT

Advancing three clinical development programs DM1, DMD, FSHD - with data anticipated from each program over the next 12 months

SAN DIEGO, Aug. 8, 2023 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs), today reported financial results and recent highlights for the second quarter ended June 30, 2023. Avidity ended the second quarter of 2023 with cash, cash equivalents and... More